Floatz logo

Continuous Microgestin 1/20

Interstitial Cystitis

Endeavor HealthUNKNOWNPhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

13 Active assets in the Interstitial Cystitis cohort.

Asset / SponsorPhaseRating
Cyclic Microgestin 1/20
Endeavor Health
Phase 4BB
Doxycycline
Insel Gruppe AG, University Hospital Bern
Phase 4B
Amitriptyline
Jocelyn Fitzgerald
Phase 3B
Gralise
Shirley Ryan AbilityLab
Phase 4B
Gabapentin
Jocelyn Fitzgerald
Phase 3B

View all 24 →

Same molecule, other indications

Continuous Microgestin 1/20 is also rated in:

dysmenorrheaDormant
BB
Indicative · Phase 4
69 / 100
View asset →
migraine disorderDormant
BB
Indicative · Phase 4
68 / 100
View asset →
endometriosisDormant
BB
Indicative · Phase 4
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →